Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Department
Adjust height of sidebar
KMap
Department
Obstetrics and Gynecology
17 active people
48 grants
Recent Grants
A Phase 3 Study of Relacorilant in Combination with Nab-Paclitaxel versus Nab-Paclitaxel Monotherapy in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tu
2023
·
$560.9K
ovarian cancer,
combination therapy,
platinum-resistant,
peritoneal cancer,
fallopian-tube cancer
Multicenter, Open-label, Phase 2 Study of Carboplatin Plus Mirvetuximab Soravtansine Followed by Mirvetuximab Soravtansine Continuation in Folate
2023
·
$419.4K
chemotherapy,
antibody-drug conjugate,
ovarian cancer,
clinical trial,
folate receptor
A Randomized Phase 3 Study Assessing the Efficacy and Safety of Olvi-Vec followed by Platinum-doublet Chemotherapy and Bevacizumab Compared with Platinum-doublet Chemotherapy and Bevacizumab in Women
2023
·
$270.2K
clinical trials,
cancer treatment,
immunotherapy,
chemotherapy,
women's health
A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study of Upifitamab Rilsodotin (XMT-1536) as Post-Platnum Maintenance Therapy for Participants with Recurrent, Platinum-Sensitive
2023
·
$217.6K
cancer therapy,
clinical trial,
pharmacology,
immunotherapy,
drug development
Ovarian Cancer Detection with Blood- and Imaging-Based Biomarkers
2022
·
$1.7M
ovarian cancer,
biomarker detection,
blood-based detection,
imaging-based detection,
cancer diagnosis
Prospective, Postmarket Study of the Desara? One Single Incision Sling vs. Desara? Blue Sling Implanted via the Transobturator Route for the Treatment of Women with Stress Urinary Incontinence
2022
·
$1.1M
urinary incontinence,
slingimplant,
transobturatorroute
Ovarian Cancer Detection with Blood- and Imaging-Based Biomarkers
2022
·
$97.1K
ovarian cancer,
biomarker detection,
blood-based detection,
imaging-based detection,
cancer diagnosis
A Randomised, Multicentre, Double-blind, Placebo-controlled, Phase III Study of First-line Carboplatin and Paclitaxel in Combination with Durvalumab, Followed by Maintenance Durvalumab with or without
2021
·
$339.8K
oncology,
immunotherapy,
clinical trial,
chemotherapy,
lung cancer
A Phase 3, Double-Blind, Placebo-Controlled, Multicenter Clinical Study Comparing Chemo-Immunotherapy (Paclitaxel-Carboplatin-Oregovomab) Versus Chemotherapy (Paclitaxel-Carboplatin-Placebo) in Patien
2020
·
$406.1K
chemo-immunotherapy,
chemotherapy
A Randomized Phase 3, Double-Blind Study of Chemotherapy With or Without Pembrolizumab Followed by Maintenance With Olaparib or Placebo for the First- Line Treatment of BRCA Non-Mutated Advanced...
2020
·
$251.3K
chemotherapy,
immunotherapy,
maintenance therapy,
brca non-mutated
A Phase Ib Study of Cobimetinib Administered in Combination With Niraparib, With or Without Atezolizumab, To Patients With Advanced Platinum-Sensitive Ovarian Cancer
2019
·
$548.3K
ovarian cancer,
combination therapy,
precision medicine,
immunotherapy,
platinum-sensitive
The OVAL Study: A Randomized, Controlled, Double-Arm, Open-Label, Multi-Center Study of Ofranergene Obadenovec (VB-111) Combined with Paclitaxel vs. Paclitaxel Monotherapy for the Treatment of...
2019
·
$243.7K
clinical trials,
cancer treatment,
gene therapy,
paclitaxel combination
ATHENA (A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response
2018
·
$129.1K
ovarian cancer,
clinical trial,
maintenance treatment,
rucaparib,
nivolumab
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Niraparib Maintenance Treatment in Patients with HRD-Positive Advanced Ovarian Cancer Following Response on Front-Line...
2016
·
$133.7K
ovarian cancer,
maintenance treatment,
hrd-positive,
niraparib
A Phase 3 Placebo-Controlled Study of Carboplatin/Paclitaxel With or Without Concurrent and Continuation Maintenance Veliparib (PARB Inhibitor) in Subjects with Previously Untreated Stages III or IV
2016
·
$101.7K
chemotherapy,
parp inhibitors,
cancer treatment,
clinical trial,
oncology
A Multicentre Randomised Phase II Study of AZD1775 Plus Chemotherapy Versus Chemotherapy Alone in Patients with Platinum-Resistant TP53-Mutated Epithelial Ovarian, Fallopian Tube, or Primary...
2015
·
$295.3K
ovarian cancer,
chemotherapy,
tp53 mutation,
clinical trial,
drug combination
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Rucaparib as Switch Maintenance Therapy Following Platinum-Based Chemotherapy in Patients with Platinum-Sensitive, High....
2015
·
$265.8K
maintenance therapy,
platinum-based chemotherapy,
rucaparib
Project Site Manager Transition
2022
·
$26.1K
project management,
site operations,
transition management,
construction,
human resources
Control of Bleeding on Nexplanon in Latinx Patients
2021
·
$369.6K
contraception,
women's health,
ethnic health disparities,
bleeding management,
implantable contraceptives
Molecular, Functional, and Microstructural Imaging of Cervical Remodeling Biomarkers
2021
·
$20K
imaging,
biomarkers,
cervical,
molecular,
microstructural
People
Amy Mitchell
Associate Professor
Chaur-Dong Hsu
Department Head
Dipali Goyal
Research Professional II
Holly Bullock
Assistant Professor, Obstetrics and Gynecology - (Clinical Scholar Track)
Heather Reed
Assistant Professor
Ilana Addis
Professor
Janiel Cragun
Associate Professor, Obstetrics and Gynecology - (Clinical Scholar Track)
John Heusinkveld
Associate Professor, Obstetrics and Gynecology - (Clinical Scholar Track)
Karen Lesser
Clinical Professor
Lynn Coppola
Assistant Professor, Obstetrics and Gynecology - (Clinical Scholar Track)
Robert Samuelson
Associate Clinical Professor, Obstetrics and Gynecology - (Clinical Series Track)
Rachel Darche
Assistant Professor, Obstetrics and Gynecology - (Clinical Scholar Track)
Steven Dudick
Assistant Clinical Professor, Obstetrics and Gynecology - (Clinical Series Track)
Setsuko Chambers
Professor
Marina Miller
Assistant Professor, Obstetrics and Gynecology - (Clinical Scholar Track)
Michelle Abbate
Assistant Clinical Professor, Obstetrics and Gynecology - (Clinical Series Track)
Victoria Fewell
Assistant Clinical Professor, Obstetrics and Gynecology - (Clinical Series Track)
Research expenses history
Funding support
7 funding agencies since 2020